Coronavirus vaccine: Oxford trials resume after brief halt post side effects
This Wednesday the company announced that it has voluntarily paused the trials of the vaccine being developed alongside Oxford University after a UK volunteer developed an unexplained illness.
Followed by this an independent committee was drafted to review the safety, which is described as a routine step by the World Health Organisation.
The AstraZeneca vaccine is being developed by researchers from Oxford University. The trials are in the last stage but were suspended after an illness in a study subject, casting doubts on an early rollout.
The patient involved in the study was reported suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
The safety reviewers have recommended to Britain’s Medical Health Regulatory Authority (MHRA) that it was safe to resume the British trials.